The ResMed Lumis 100 VPAP ST Non-Invasive Ventilator is engineered to provide personalized ventilation for patients with respiratory insufficiency. Its user-friendly design and advanced features make it an ideal choice for both healthcare professionals and patients seeking effective respiratory support.

Key Features:

• IntelligentAir Technology: Tailors therapy to individual breathing needs through:
  • Vsync: Ensures excellent patient–ventilator synchrony, even with significant leaks.
  • TiControl™: Allows setting minimum and maximum inspiratory time limits to encourage spontaneous breathing.
  • Trigger and Cycle Sensitivity: Optimizes settings with five sensitivity levels.
  • QuickNav: Enables quick adjustments by toggling between settings and monitoring screens.
  • Climate Control Auto: Delivers automatic humidification when used with compatible accessories.
  • Ramp and Ramp Down: Provides comfort during therapy initiation and conclusion.
• ResScan Software Compatibility: Offers advanced clinical insights, allowing healthcare providers to monitor therapy progress and adjust settings as needed.

Specifications:

• Dimensions: Approximately 25 cm (L) x 20 cm (W) x 15 cm (H)
• Weight: Approximately 2.5 kg
• Manufacturing Country: Australia
• Certifications: CE Marked, ISO 13485 Certified

Scope of Supply:

• ResMed Lumis 100 VPAP ST Non-Invasive Ventilator Unit
• User Manual
• Power Supply Cord
• Air Tubing
• Filters

Advantages of Use:

• Personalized Therapy: Adjusts to individual patient needs, enhancing comfort and compliance.
• Advanced Technology: Incorporates IntelligentAir for optimal patient-ventilator synchrony.
• Ease of Use: Features intuitive controls and QuickNav for efficient adjustments.
• Automatic Humidification: Climate Control Auto ensures consistent humidification without manual settings.
• Clinical Insights: ResScan software provides detailed therapy data for informed decision-making.

Company Profile:

ResMed Inc., founded in 1989 in Australia, is a leading global company specializing in cloud-connected medical devices for the treatment of sleep apnea, chronic obstructive pulmonary disease (COPD), and other respiratory conditions. With a presence in over 140 countries and manufacturing facilities in Australia, Singapore, France, and the United States, ResMed employs more than 8,000 people worldwide. The company’s commitment to innovation and quality has positioned it as a trusted provider of respiratory care solutions.